C57BL/6NCrl-Apcem1(IMPC)Ccpcz/Ph

Status

Under development - register interest

EMMA IDEM:16663
Citation informationRRID:IMSR_EM:16663 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6NCrl-Apcem1(IMPC)Ccpcz/Ph
Alternative name
Strain typeEndonuclease-mediated
Allele/Transgene symbolApcem1(IMPC)Ccpcz
Gene/Transgene symbolApc

Information from provider

Provider Institute of Molecular Genetics
Provider affiliationDepartment of Transgenic Models of Diseases, Institute of Molecular Genetics
Genetic informationThis mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreInstitute of Molecular Genetics, Prague, Czech Republic

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

MGI phenotypes (gene matching)
  • absent mandible / MGI
  • decreased hematocrit / MGI
  • increased cell proliferation / MGI
  • abnormal digestive system morphology / MGI
  • gastrointestinal hemorrhage / MGI
  • abnormal foregut morphology / MGI
  • abnormal crypts of Lieberkuhn morphology / MGI
  • rectal prolapse / MGI
  • abnormal intestinal mucosa morphology / MGI
  • abnormal mammary gland development / MGI
  • mammary gland hyperplasia / MGI
  • abnormal brain development / MGI
  • abnormal floor plate morphology / MGI
  • abnormal ovarian folliculogenesis / MGI
  • abnormal ovarian follicle morphology / MGI
  • absent mature ovarian follicles / MGI
  • absent corpus luteum / MGI
  • abnormal vagina epithelium morphology / MGI
  • dermal cysts / MGI
  • decreased body weight / MGI
  • decreased body size / MGI
  • increased metastatic potential / MGI
  • abnormal nursing / MGI
  • hunched posture / MGI
  • hyperlipidemia / MGI
  • increased circulating triglyceride level / MGI
  • increased circulating free fatty acid level / MGI
  • anemia / MGI
  • extended life span / MGI
  • abnormal embryo development / MGI
  • abnormal embryo size / MGI
  • decreased embryo size / MGI
  • incomplete embryo turning / MGI
  • postnatal growth retardation / MGI
  • increased mammary adenocarcinoma incidence / MGI
  • neoplasm / MGI
  • increased pilomatricoma incidence / MGI
  • increased tumor incidence / MGI
  • increased incidence of induced tumors / MGI
  • increased colon adenoma incidence / MGI
  • premature death / MGI
  • abnormal developmental patterning / MGI
  • abnormal embryonic tissue morphology / MGI
  • abnormal neural tube morphology / MGI
  • no abnormal phenotype detected / MGI
  • increased intestinal adenoma incidence / MGI
  • hepatic steatosis / MGI
  • increased trichoepithelioma incidence / MGI
  • increased intestinal adenocarcinoma incidence / MGI
  • no phenotypic analysis / MGI
  • abnormal egg cylinder morphology / MGI
  • acrania / MGI
  • colon polyps / MGI
  • intestinal obstruction / MGI
  • melena / MGI
  • rectal hemorrhage / MGI
  • gastric polyps / MGI
  • increased hepatocellular carcinoma incidence / MGI
  • epidermal cyst / MGI
  • decreased tumor growth/size / MGI
  • abnormal tumor morphology / MGI
  • abnormal intestinal goblet cell morphology / MGI
  • increased tumor growth/size / MGI
  • increased osteosarcoma incidence / MGI
  • decreased macrophage cell number / MGI
  • abnormal embryonic epiblast morphology / MGI
  • aneuploidy / MGI
  • abnormal primitive node morphology / MGI
  • cardia bifida / MGI
  • increased incidence of tumors by chemical induction / MGI
  • split notochord / MGI
  • ovary atrophy / MGI
  • abnormal large intestine crypts of Lieberkuhn morphology / MGI
  • uterus atrophy / MGI
  • decreased T cell number / MGI
  • increased circulating cholesterol level / MGI
  • cellular phenotype / MGI
  • reproductive system phenotype / MGI
  • abnormal cell physiology / MGI
  • increased apoptosis / MGI
  • abnormal hindbrain development / MGI
  • absent male preputial gland / MGI
  • intestine polyps / MGI
  • increased liver tumor incidence / MGI
  • decreased NK cell number / MGI
  • abnormal anterior visceral endoderm morphology / MGI
  • embryonic lethality / MGI
  • abnormal enterocyte proliferation / MGI
  • adrenal gland hyperplasia / MGI
  • abnormal mesendoderm development / MGI
  • increased small intestine adenocarcinoma incidence / MGI
  • increased large intestine adenocarcinoma incidence / MGI
  • decreased splenocyte number / MGI
  • abnormal pregnancy / MGI
  • absent nipple / MGI
  • increased prostaglandin level / MGI
  • embryonic lethality between implantation and placentation / MGI
  • increased gastrointestinal tumor incidence / MGI
  • increased mammary gland tumor incidence / MGI
  • increased skin tumor incidence / MGI
  • increased stomach tumor incidence / MGI
  • increased osteoma incidence / MGI
  • increased desmoid tumor incidence / MGI
  • gastrointestinal tract polyps / MGI
  • increased adenoma incidence / MGI
  • altered tumor pathology / MGI
  • mortality/aging / MGI
  • postnatal lethality, complete penetrance / MGI
  • postnatal lethality, incomplete penetrance / MGI
  • perinatal lethality, complete penetrance / MGI
  • prenatal lethality, complete penetrance / MGI
  • embryonic lethality, complete penetrance / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI
  • embryonic lethality between implantation and somite formation, incomplete penetrance / MGI
  • lethality throughout fetal growth and development, incomplete penetrance / MGI
  • absent midbrain / MGI
  • embryonic-extraembryonic boundary constriction / MGI
  • absent forebrain / MGI
  • rostral-caudal axis duplication / MGI
  • rostral body truncation / MGI
  • absent neural folds / MGI
  • abnormal head development / MGI
  • decreased intestinal adenoma incidence / MGI
  • abnormal endocardial heart tube morphology / MGI

Information on how we integrate external resources can be found here

Register interest

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).